If only...
Zotefoams (LSE: ZTF) makes cellular foams for markets including aerospace, automotive, packaging and sports and leisure. It has its headquarters and manufacturing base in Croydon, with facilities in the US and China. The business is growing nicely and is spending £31m on expanding its Kentucky plant to increase its global capacity by 20%. It recently announced a strategic partnership with Nike, which boosted the share price by 14% to hit a record high.
Be glad you didn't
High-street retailer Debenhams (LSE: DEB) has been struggling for a while as it battles competition from online sellers. A turnaround strategy announced in April 2017 was aimed at "simplifying and focusing operations". But 2017 profits fell 44%, despite a 2.1% rise in like-for-like sales. Shareholders have had a tough year it is the second-most shorted stock on the London market and the price is down by more than 40% in the last year.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
-
Christmas at Chatsworth: review of The Cavendish Hotel at BaslowMoneyWeek Travel Matthew Partridge gets into the festive spirit at The Cavendish Hotel at Baslow and the Christmas market at Chatsworth
-
Tycoon Truong My Lan on death row over world’s biggest bank fraudProperty tycoon Truong My Lan has been found guilty of a corruption scandal that dwarfs Malaysia’s 1MDB fraud and Sam Bankman-Fried’s crypto scam
-
Debenhams is the latest retailer to go downFeatures The group fell into administration this week, marking another setback for Sports Direct founder Mike Ashley. Matthew Partridge reports.
-
Drama at DebenhamsFeatures The outlook at department store group Debenhams is dismal, while Mike Ashley, who owns 30% of it, has been putting his oar in. Matthew Partridge reports.
-
Debenhams calls in the company doctorsFeatures Early this week, the group seemed at death’s door. The prognosis is not quite that bad – but it’s not good news either. Alice Gråhns reports.
-
Little cheer on the high streetFeatures Profit warnings from Debenhams and Mothercare are more evidence that traditional retailers are fighting a losing battle against nimbler online competitors, says Ben Judge.
-
Three contrarian stocks to buy nowOpinion Professional investor Paul Mumford look for shares that offer solid long-term growth potential, which look undervalued. Here, he picks three such contrarian stocks to buy now.
-
Debenhams beats expectations, announces buy-back
News Half-year profits at High Street retail chain Debenhams were ahead of market forecasts, giving the board confidence the department store group will hit full year expectations.
